MDI and DPI Drug Products
...Documentation in Drug Applications for Container and Closure Systems Used for the.....manufacturing, processing, packaging, controls, stability testing, or labeling operations.....establish a set of criteria to which a drug substance or drug product should conform using..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)

Packaging
...Samples of a drug that are selected for stability studies should be packaged in the container/clsoure system in which.....If a medicine dropper is incorporated as an integral part of the drug container or closure.....In these early stages, the IND should also indicate that appropriate stability studies..
http://www.fda.gov/cder/guidance/package.htm (score=93)

Format and Content for the CMC Section of an Annual Report
...the design of stability protocols, the amount of stability data that should be provided to.....Regulatory specifications and analytical methods for the drug substance and drug..product should be listed.....during the reporting period, including immediate container labels, carton..labeling, and..
http://www.fda.gov/cder/guidance/cmc1.pdf (score=93)

Guidance for Industry
...medical gas would be tested for stability in the exact container closure system that it is.....adverse drug experience, which is required to be reported to the Food and Drug.....container and attached it to the container containing argon, and was able to fill the..
http://www.fda.gov/OHRMS/DOCKETS/98fr/03d-0165-gdl0001.pdf (score=88)

HUMAN DRUG CGMP NOTES, June 1997
...Except for large containers, a random sample should be collected from an unopened.....Because in large containers dosage units near the closure may have different stability.....Welcome to another edition of Human Drug CGMP Notes, our periodic memo on CGMP for human..
http://www.fda.gov/cder/hdn/cnotes67.htm (score=85)

PET Drug Products … Current Good Manufacturing Practice (CGMP)
...or lot, of a PET drug typically consists of one multiple-dose vial containing the PET drug.....stability parameters include radiochemical identity and purity, appearance, pH, stabilizer.....made to verify that the correct label has been affixed to the container and the shield..
http://www.fda.gov/cder/guidance/4259dft.pdf (score=82)

PET Drug Products - Current Good Manufacturing Practice (CGMP)
...Appropriate parameters should be evaluated to establish and document the stability of a PET drug product.....Container assemblies should be prepared at the beginning of the day before other daily.....Stability testing of the PET drug product should be performed at the highest radioactive concentration, and the whole..
http://www.fda.gov/cder/guidance/4259dft.htm (score=81)

Guidanc for Industry: Container and Closure Integrity Testing in Lieu of...
...test with an appropriate container and closure integrity test in the stability protocol.....ICH final guideline is intended to supplement the tripartite ICH guideline entitled, "Stability..Testing of New Drug.....than sterility testing to confirm container and closure integrity as a part of stability..
http://www.fda.gov/cber/gdlns/contain.pdf (score=96)

Consistent Container Information in an Abbreviated Application
...The stability section only describes the container as made from"HDPE resin with a metal.....batch number and strength of the drug product used, the source of the active drug..substance, and the tests performed in the stability.....To ensure that generic drug firms provide consistent descriptions of container..
http://www.fda.gov/cder/mapp/5225-2.pdf (score=96)

stability guidance -draft
...between the drug and the container and closure and the potential introduction of.....compromise the quality, purity, or stability of the drug substance and the resulting drug.....the manufacturer may elect to place only the smallest and largest container size into the..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=91)

Human Drug Notes
...The problems we have seen are usually not with the product itself, but rather with the.....Where an expiration dating period is derived from stability studies conducted on the.....Welcome to the first edition of our fourth year of Human Drug CGMP Notes, our periodic..
http://www.fda.gov/cder/hdn/hdn396.htm (score=88)

X:TRANSFERGUIDANCEFINAL 807FN1.PDF
...The stability of drug..products needs to be evaluated over time in the same container-closure system in.....have made good faith efforts to comply with the stability testing requirements but were.....The Federal Food, Drug, and Cosmetic Act requires that manufacturers establish controls..
http://www.fda.gov/cder/guidance/1807fn1.pdf (score=87)

...For 18 instance, ingress of volatile chemicals might 19 adversely affect the stability of the active drug 20.....area, fills 2 the container, and it withdraws, and then the 3 container is sealed and.....1 DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH DRUG..
http://www.fda.gov/ohrms/dockets/ac/04/transcripts/2004-4040T1.DOC (score=86)

FDA Concept Paper: Drug Products That Present Demonstrable Difficulties for...
...Factors such as drug stability in the vehicle, the specific product use, and the site of.....In addition, a product filler capable of reproducing an exact fill amount from container to container.....In addition, careful control of the impurities and degradation products in the drug substance and drug..
http://www.fda.gov/cder/fdama/difconc.htm (score=86)

Human Drug Notes
...While the expiration dating assigned to such products would be based on the stability of the drug product, stability.....container before the drug is depleted or before the drug reaches its expiration date. The.....container stopper. Furthermore, injectable drug products in multi-dose containers are..
http://www.fda.gov/cder/hdn/hdn995.htm (score=85)

HUMAN DRUG CGMP NOTES September 1996
...A bottle cap is part of the immediate container closure system, but is not the immediate.....Failing to submit annual reports or excluding specific lots from the stability program in.....What types of failures must a batch of new drug product exhibit to trigger a field alert..
http://www.fda.gov/cder/hdn/hdn996.htm (score=85)

HUMAN DRUG CGMP NOTES June 2000
...These include guidance documents pertaining to stability testing and container-closure.....What FDA guidance documents pertain to drug repackaging operations and how can they be.....Just as the container-closure system chosen by a firm needs to be a robust one to ensure..
http://www.fda.gov/cder/hdn/cnotes0600.htm (score=84)

Microsoft Word - 5320.1.doc
...Container Closure System..Description of the container-closure system used for the drug.....2 Post-Approval Stability Protocol and Stability Commitment.. Analytical procedures and testing schedule for.....Description of the Composition of the Drug Product..Description of the drug product..
http://www.fda.gov/cder/mapp/5320.1.pdf (score=83)

Guidance- Content & Format CMC for Vaccine & Related Product
...This section should contain information on the stability of the drug substance and any in.....A description of the container and closure system, and its compatibility with the drug.....material at each holding step, as outlined in "Stability Testing of New Drug Substances..
http://www.fda.gov/cber/gdlns/cmcvacc.pdf (score=83)

Microsoft Word - 5666fnl.doc
...8 In June 1998, the Agency issued a draft guidance on stability testing, Stability Testing of Drug Substances.....the container closure system when stored according to labeled directions. To date, the.....lot-to-lot variability, the stability and quality of drug products with extended..
http://www.fda.gov/cder/guidance/5666fnl.pdf (score=83)

Las Vegas Injury Lawyer